Navigation Links
Genmab A/S - R1507 Antibody to Enter Phase II Study to Treat Sarcoma
Date:12/20/2007

Summary: Genmab's Partner, Roche has Initiated a Phase II study of R1507

for the Treatment of Sarcoma

COPENHAGEN, Denmark, December 20 /PRNewswire-FirstCall/ -- Genmab A/S (OMX: GEN) announced today that its partner, Roche has initiated a Phase II clinical study of R1507 for the treatment of recurrent or refractory sarcoma. The R1507 antibody was created by Genmab under the company's agreement with Roche and initiation of the trial will trigger a milestone payment to Genmab of USD 500,000.

"R1507 will be the first antibody created by Genmab under our agreement with Roche to enter Phase II development," said Lisa N. Drakeman, Ph.D., Chief Executive Officer of Genmab. "We believe that R1507 may offer an additional treatment option to sarcoma patients."

About Sarcoma

Sarcoma is a cancer of the connective tissue including muscle, bone, fat, nerve, cartilage, blood vessel and deep skin tissue. Due to the wide variety of types of sarcoma, the disease is often difficult to detect, is often misdiagnosed and is complex to treat. Sarcoma is a rare type of cancer with US incidence of approximately 9,000 to 11,000 new cases per year. Of these approximately 8,000 are cases of soft tissue sarcoma and 2,000 are sarcoma of the bone.

About Genmab A/S

Genmab is a leading international biotechnology company focused on developing fully human antibody therapeutics for unmet medical needs. Using unique, cutting-edge antibody technology, Genmab's world class discovery and development teams have created and developed an extensive pipeline of products for potential treatment of a variety of diseases including cancer and autoimmune disorders. As Genmab advances towards a commercial future, we remain committed to our primary goal of improving the lives of patients who are in urgent need of new treatment options. For more information on Genmab's products and technology, visit
'/>"/>

SOURCE Genmab A/S
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Genmab Announces 2007 First Half Year Results
2. Genmab Announces Encouraging Preclinical Data for ofatumumab
3. Genmab Discloses Target and Development Plans for HuMax-Inflam
4. Genmab Announces Asset Exchange Agreement
5. Genmab Amends Ofatumumab Pivotal Study in NHL to Single Arm Study
6. Genmab A/S - Company Announcement
7. Genmab Amends HuMax-CD4 Pivotal Study in CTCL
8. Phase I Results Announced for R1507 From Genmabs Collaboration With Roche
9. Genmab Announces Results for the First Nine Months of 2007
10. Genmab Announces Update on Recruitment of Patients in ofatumumab CLL Pivotal Study
11. Fourth Genmab Antibody Developed Under Roche Collaboration to Enter Clinic
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/11/2014)... Fla. , Sept. 11, 2014 /PRNewswire/ ... anti-infective pharmaceuticals, announced today that the United ... a ,Notice of Allowance, for patent application ... Uses,.  The ,486 patent application relates to ... through gene-silencing and can be designed to ...
(Date:9/11/2014)... Entries are now being accepted for the annual ... colleagues within the healthcare industry select who wins. Now in ... best in healthcare creative campaigns. The awards are unique in ... and wellness industry. All entries are placed online, and healthcare ... each category. , “No one knows what it takes ...
(Date:9/11/2014)... September 11, 2014 Genera Energy ... innovation and supply chain advancements, recently introduced its newest ... BIN-SPEC delivers a consistent biomass product to a customer’s ... a lower cost. , “After producing and harvesting ... place to convert a field crop into a uniform ...
(Date:9/11/2014)... 11, 2014 Central Florida board-certified veterinary ... partnerships with several Brevard County animal hospitals to bring ... been working in the area since January 2006, credentialed ... 2008, and is happy to now offer his expertise ... Christiansen has used stem cell therapy with Vet-Stem, Inc. ...
Breaking Biology Technology:Lakewood-Amedex Receives Notice Of Allowance From The United States Patent and Trademark Office (USPTO) For A New Patent Covering Its nanoRNA Gene-Silencing Technology 2Lakewood-Amedex Receives Notice Of Allowance From The United States Patent and Trademark Office (USPTO) For A New Patent Covering Its nanoRNA Gene-Silencing Technology 3PM360 Now Accepting Entries for 2014 Pharma Choice Awards 2Genera Energy’s BIN-SPEC™ Reduces Biomass Feedstock Variability 2Genera Energy’s BIN-SPEC™ Reduces Biomass Feedstock Variability 3Dr. Jeff Christiansen is Now Offering Stem Cell Therapy for Pets at Five Brevard County Animal Hospitals and Beyond 2Dr. Jeff Christiansen is Now Offering Stem Cell Therapy for Pets at Five Brevard County Animal Hospitals and Beyond 3
... ON - Clean solutions to human energy demands are essential ... of energy at our disposal, we have yet to learn ... According to University of Toronto chemistry professor Greg Scholes, the ... in nature. "Solar fuel production often starts with the ...
... Citizens Bank today announced that it is providing $70 ... The Wistar Institute that includes a new seven-story 89,700-square-foot ... and Spruce streets in University City. The ... basic biomedical research, particularly cancer research and vaccine development ...
... first laser in 1960 scientists discovered that shining a beam ... specifically, it produced light of exactly twice the frequency of ... The green laser pointers in use today to illustrate ... beautiful emerald beam is no easy feat. The green light ...
Cached Biology Technology:Nature offers key lessons on harvesting solar power, says U of T chemistry professor 2Citizens Bank Provides $70 Million in Financing Toward $100 Million Expansion of The Wistar Institute 2Stanford engineers create nanoscale nonlinear light source 2Stanford engineers create nanoscale nonlinear light source 3Stanford engineers create nanoscale nonlinear light source 4
(Date:9/12/2014)... and condition of extraction of type I collagen fibrils, ... of their circular circular cross sections stay distributed in ... the most part of them. Jean Charvolin and Jean-Francois ... Paris-Sud University propose therefore that, once the growth of ... their lateral size be limited by internal physical stresses ...
(Date:9/12/2014)... to dealing with climate change: Advances in hydraulic ... unreachable oil and natural gas within humanity,s grasp. ... from "fracking," which requires blasting huge amounts of ... formations, are the subject of new research that ... survey covers not only greenhouse gas impacts but ...
(Date:9/12/2014)... and POINT ROBERTS, Washington , ... Investorideas.com ( http://www.investorideas.com ) a global news source covering leading ... and experts on the September 9 th launch of ... of Goode Intelligence, Janice Kephart , founder of the ... Pereira of NXT-ID, Inc, (NASDAQ: NXTD ) ...
Breaking Biology News(10 mins):Conjecture on the lateral growth of Type I collagen fibrils 2Stanford-led study assesses the environmental costs and benefits of fracking 2Stanford-led study assesses the environmental costs and benefits of fracking 3Stanford-led study assesses the environmental costs and benefits of fracking 4Biometric Experts Comment on Launch of Apple Pay Smart Wallet Payment Service 2Biometric Experts Comment on Launch of Apple Pay Smart Wallet Payment Service 3Biometric Experts Comment on Launch of Apple Pay Smart Wallet Payment Service 4Biometric Experts Comment on Launch of Apple Pay Smart Wallet Payment Service 5
... cryo-electron microscopes, researchers at Baylor College of Medicine unmasked the ... doing so, opened the door to a better understanding of ... In a report that appears in and on the cover ... Chiu, professor in the BCM department of biochemistry and molecular ...
... Low-grade uranium ore is nicknamed "yellowcake" for its color ... or "yellow monster." , The yellow monster surfaced on ... the 1940s and continued for the next several decades. ... among mine workers and worries about environmental contamination among ...
... at Virginia Tech, Colorado State University, and Duke ... to determine gene function on a genome-wide scale ... fungus causes black spot disease, leading to considerable ... canola, cabbage, and broccoli. , Genomic methods ...
Cached Biology News:Unraveling the viral mechanism 2Study may help slay 'Yellow Monster' 2Study may help slay 'Yellow Monster' 3New method enables gene disruption in destructive fungal pathogen 2
Collected from calves that are 10 days old or less. Sterile, cell culture tested, US Origin...
... Whole Genome Amplification Kit utilizes a ... of genomic DNA and conversion of ... library molecules flanked by universal priming ... amplification of the library molecules using ...
... ultra-pure recombinant thermostable DNA polymerase obtained by ... polymerase gene in E. coli, Concentration: 5U/ul, ... Thermo Fisher Scientific, the world leader in ... to make the world healthier, cleaner and ...
... Analysis of large numbers of samples may ... system which requires minimum operator attention. ... PowerStream software and interface CE 4900. The ... operates in Windows XP and Windows 98 and ...
Biology Products: